Mandate

Vinge advised Equinor in connection with its investment in Medfield Diagnostics

November 21, 2018 Capital Markets and Public M&A

Vinge advised Equinor Technology Ventures AS (”Equinor”) in connection with its acquisition in Medfield Diagnostics Aktiebolag (publ) (“Medfield”).

The investment will be made through a directed issue to Equinor as well as a rights issue of shares. Medfield is listed on Spotlight.
Equinor ASA is a global energy company with more than 20,000 employees and business in more than 30 countries. Equinor is the largest oil and gas operator in Norway, one of the largest offshore operators globally and has a growing portfolio of renewable assets in wind and solar power.

Equinor Technology Ventures AS invests in technology companies with major implementation potential in the company’s core business. Since its establishment, ETV has invested in more than 60 companies and financed over 260 product developments.

Vinge’s team consisted of Dain Hård Nevonen, Peter Sundgren, Rikard Lindahl, Amanda Knutsson and Peter Issa. 

Related

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026

Vinge advises on the sale of Compab to Tången

Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026